Satlyt
Software that lets satellite operators run additional applications and AI workloads on existing spacecraft.
$8MSeed
ParticipantG
Gaingels
Activity from announced rounds
Activity in this selectionAI
Gaingels co-invests alongside venture leads in companies committed to diverse and inclusive teams, spanning seed through growth and pre-IPO rounds across technology, healthcare and consumer markets.
Its investor community includes LGBTQ+ people and allies, extending representation within the ownership of venture-backed companies. Portfolio companies work with its Gaingels Letter commitments and Venture Inclusion programme on building more inclusive organisations.
A board access programme provides free recruitment advice for diverse board members and observers. This gives founders a practical governance resource alongside a co-investment partner for a round led by another venture firm.
Sources
- Rounds participated in
- 13
- Confirmed lead rounds
- 0 10 roles undisclosed
- New companies
- 13 First participation on record · 0 follow-on
- Funding in participating rounds
- $611.9M 12 disclosed · full round size, not this investor’s share
By stage
By primary sector
3 more
Hardware1
Mobility1
Space tech1
By country
Rounds
13 in this selectionSuperluminal Medicines
Superluminal Medicines combines structural biology, protein dynamics, machine learning and experimental testing to discover small-molecule drugs for difficult G protein-coupled receptor targets. Its pipeline focuses on endocrine and cardiometabolic diseases, including rare genetic and hypothalamic obesity.
$60MSeries B
ParticipantConcordare Trials
Converts clinical trial protocol PDFs into structured digital format
UndisclosedUndisclosed
Role not disclosedStandard Metrics
AI-driven portfolio management platform for VC and private equity firms
$20MSeries B
Role not disclosedHellbender
Builds integrated edge AI perception platforms and cameras for autonomous and industrial systems
$12.5MSeed
Role not disclosedKanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosedLatus Bio, Inc.
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
$97MSeries A
Role not disclosedAlloy Therapeutics
Drug discovery platforms and integrated development services for biotechnology and pharmaceutical partners.
$40MSeries E
Role not disclosedNitra
AI-native operating system for healthcare practices to automate back office functions
$187MSeries A+Series B+Debt
Role not disclosedRenoFi
Provides AI-enabled renovation financing platform for homeowners
$22MSeries B
Role not disclosedAndo
Ando develops demand forecasting and workforce scheduling tools for businesses employing hourly workers.
$4MSeed
ParticipantEmobi
Emobi provides EV charging connectivity across networks.
$3.4MSeed
Role not disclosedNeurophos
Develops photonic AI inference chips for data centers
$110MSeries A
Role not disclosed